India's Marksans Pharma rises after Q1 profit boost
** Shares of Marksans Pharma MARK.NS up 9.4% at 205.4
rupees, its steepest gain since July 24
** Pharmaceutical formulations maker's Q1 consol net profit
grew ~30%, rev up 18%
** Shares see busiest day in about 3 weeks, with over 3.2
mln shares traded
** Stock up 28% YTD, vs an 81% and 9% rise in peers Natco
Pharma NATP.NS and Mankind Pharma MNKI.NS , respectively
(Reporting by Aleef Jahan in Bengaluru)
((aleefjahan.cs@thomsonreuters.com))
Recent news on Mankind Pharma
See all newsIndia's Mankind Pharma heads for best day in over 3 years as Q2 hints at recovery
Mankind Pharma's quarterly profit jumps 39% on strong chronic drug demand
India's Mankind Pharma gains on higher quarterly profit
Brief: Mankind Pharma Says To Buy 70% Majority Stake In Armed Cell Therapeutics Through Unit
Kotak upgrades India's Mankind Pharma to 'buy' on signs of business recovery